
Register For Free	New user? Register Here

Overview
Scope
Career Opportunities
Top Companies
Other Biotech Companies
Recent Developments

Biocon granted marketing license of its cancer drug to Ferozsons labs

Biocon granted exclusive marketing license of Biomab EGFR, biotech molecule for the treatment of cancer, to Ferozsons Laboratories Ltd

of Pakistan. The Pakistan oncology market is valued at nearly $70 million. Biomab EGFR has entered the rapidly growing monoclonal sector that has annual growth rate of about 30%. Biomab EGFR is used in the treatment of neck and head cancer.